Eluminex is committed towards developing first- and/or best-in-class protein therapeutics for dermal aesthetics, regenerative medicine, and vision-threatening diseases – to help patients look better and see better.
Global partnerships provide the opportunity for us to continue to build an innovative portfolio of advanced protein therapeutics in aesthetics or ophthalmic diseases and offer an entry point for the development of new treatments for the global market.
With extensive experience in global product development (drugs, devices, and combinations), our team can help maximize the value of an innovative technology towards a shared goal of benefiting patients with needs in dermal aesthetics or vision-impairing diseases.
If you have a novel development candidate drug or injectable device that could complement our current pipeline in aesthetics or ophthalmics, Eluminex Biosciences can help mutually develop the next generation of therapeutics. We want to hear from you. We also seek strategic partners for global clinical development and commercialization of our ophthalmic and aesthetic programs.